日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Campylobacter curvus Cysteine--tRNA ligase (cysS) CSB-YP414843CWB
CSB-EP414843CWB
CSB-BP414843CWB
CSB-MP414843CWB
CSB-EP414843CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Proline--tRNA ligase (proS) CSB-YP414844CWB
CSB-EP414844CWB
CSB-BP414844CWB
CSB-MP414844CWB
CSB-EP414844CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 60 kDa chaperonin (groL), partial CSB-YP414845CWB
CSB-EP414845CWB
CSB-BP414845CWB
CSB-MP414845CWB
CSB-EP414845CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 50S ribosomal protein L19 (rplS) CSB-YP414846CWB
CSB-EP414846CWB
CSB-BP414846CWB
CSB-MP414846CWB
CSB-EP414846CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 50S ribosomal protein L7/L12 (rplL) CSB-YP414847CWB
CSB-EP414847CWB
CSB-BP414847CWB
CSB-MP414847CWB
CSB-EP414847CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP414848CWB
CSB-EP414848CWB
CSB-BP414848CWB
CSB-MP414848CWB
CSB-EP414848CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Glutamate--tRNA ligase 2 (gltX2) CSB-YP414849CWB
CSB-EP414849CWB
CSB-BP414849CWB
CSB-MP414849CWB
CSB-EP414849CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Undecaprenyl-diphosphatase (uppP) CSB-YP414850CWB
CSB-EP414850CWB
CSB-BP414850CWB
CSB-MP414850CWB
CSB-EP414850CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 30S ribosomal protein S13 (rpsM) CSB-YP414851CWB
CSB-EP414851CWB
CSB-BP414851CWB
CSB-MP414851CWB
CSB-EP414851CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 50S ribosomal protein L14 (rplN) CSB-YP414852CWB
CSB-EP414852CWB
CSB-BP414852CWB
CSB-MP414852CWB
CSB-EP414852CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 50S ribosomal protein L23 (rplW) CSB-YP414853CWB
CSB-EP414853CWB
CSB-BP414853CWB
CSB-MP414853CWB
CSB-EP414853CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Chorismate synthase (aroC) CSB-YP414854CWB
CSB-EP414854CWB
CSB-BP414854CWB
CSB-MP414854CWB
CSB-EP414854CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP414855CWE
CSB-EP414855CWE
CSB-BP414855CWE
CSB-MP414855CWE
CSB-EP414855CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Orotate phosphoribosyltransferase (pyrE) CSB-YP414856CWE
CSB-EP414856CWE
CSB-BP414856CWE
CSB-MP414856CWE
CSB-EP414856CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Polyphosphate kinase (ppk), partial CSB-YP414857CWE
CSB-EP414857CWE
CSB-BP414857CWE
CSB-MP414857CWE
CSB-EP414857CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei tRNA (guanine-N (7)-)-methyltransferase CSB-YP414858CWE
CSB-EP414858CWE
CSB-BP414858CWE
CSB-MP414858CWE
CSB-EP414858CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei UvrABC system protein C (uvrC), partial CSB-YP414859CWE
CSB-EP414859CWE
CSB-BP414859CWE
CSB-MP414859CWE
CSB-EP414859CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei S-ribosylhomocysteine lyase (luxS) CSB-YP414860CWE
CSB-EP414860CWE
CSB-BP414860CWE
CSB-MP414860CWE
CSB-EP414860CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Ribosomal protein L11 methyltransferase (prmA) CSB-YP414861CWE
CSB-EP414861CWE
CSB-BP414861CWE
CSB-MP414861CWE
CSB-EP414861CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Serine/threonine transporter sstT (sstT), partial CSB-YP414862CWE
CSB-EP414862CWE
CSB-BP414862CWE
CSB-MP414862CWE
CSB-EP414862CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×